Skip to main content

Cancer startup raises $125M for Keytruda combo drug trial

RA Capital and Boxer Capital continued a busy financing week, investing undisclosed amounts in a local startup working with cancer giant Merck & Co.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.